Valuation: GC Cell Corporation

Market Cap 15TCr 11Cr 9.88Cr 9.07Cr 8.24Cr 15Cr 1.05TCr 16Cr 108.28Cr 44Cr 552.67Cr 41Cr 41Cr 1.75TCr P/E 2024
-4.82x
P/E 2025 -1.37x
Enterprise Value 23TCr 17Cr 15Cr 14Cr 13Cr 24Cr 1.6TCr 24Cr 165.67Cr 67Cr 845.56Cr 63Cr 62Cr 2.68TCr EV / Sales 2024
2.5x
EV / Sales 2025 2.73x
Free-Float
52.42%
Yield 2024 *
-
Yield 2025 -
1 day-1.98%
1 week-23.63%
Current month-2.08%
1 month-32.17%
3 months-27.06%
6 months-58.36%
Current year-60.20%
1 week 9,700
Extreme 9700
10,430
1 month 9,700
Extreme 9700
15,480
Current year 9,700
Extreme 9700
28,200
1 year 9,700
Extreme 9700
28,450
3 years 9,700
Extreme 9700
48,800
5 years 9,700
Extreme 9700
1,25,800
10 years 9,700
Extreme 9700
1,50,700
Manager TitleAgeSince
Chief Executive Officer 55 27/03/2024
Chief Executive Officer 60 25/03/2025
Sales & Marketing 57 -
Director TitleAgeSince
Director/Board Member 60 25/03/2025
Director/Board Member 55 27/03/2024
Director/Board Member 64 13/09/2021
Date Insider Type Main position Quantity % Market Cap. Importance
12/05/25 Buy

Chief Executive Officer

286 0.0018%
12/05/25 Buy

Chief Executive Officer

2,697 0.0171%
23/04/25 Free 5,000 0.0316%
Change 5-day change 1-year change 3-year change Capi.($)
-1.98%-23.63%-60.20%-66.47% 11Cr
+3.28%+0.31%+16.53%+30.12% 12TCr
-1.04%+2.87%+0.28%+100.51% 9.67TCr
+2.56%-5.40%+96.05%+809.29% 5.6TCr
+4.39%+1.61%-4.61%+85.70% 3.08TCr
-0.47%+6.87%+37.26%+68.36% 2.87TCr
-1.50%+1.86%+38.15%+84.50% 2.72TCr
-0.82%+1.77%+32.42%+385.60% 2.12TCr
+2.20%-4.21%-20.44%-14.86% 1.95TCr
+0.26%-0.64%-6.04%+29.45% 1.68TCr
Average +0.14%-0.18%+12.94%+151.22% 4.14TCr
Weighted average by Cap. -0.58%+0.56%+22.92%+178.42%

Financials

2024 2025
Net sales 17TCr 13Cr 12Cr 11Cr 9.67Cr 18Cr 1.23TCr 19Cr 127.1Cr 51Cr 648.74Cr 49Cr 48Cr 2.06TCr 17TCr 12Cr 11Cr 10Cr 9.18Cr 17Cr 1.17TCr 18Cr 120.6Cr 49Cr 615.53Cr 46Cr 45Cr 1.95TCr
Net income -7.39TCr -5.5Cr -4.91Cr -4.51Cr -4.1Cr -7.69Cr -520.68Cr -7.89Cr -54Cr -22Cr -274.81Cr -21Cr -20Cr -871.04Cr -27TCr -20Cr -18Cr -17Cr -15Cr -28Cr -1.92TCr -29Cr -198.8Cr -80Cr -1.01TCr -76Cr -75Cr -3.22TCr
Net Debt 7.96TCr 5.92Cr 5.29Cr 4.86Cr 4.41Cr 8.29Cr 560.77Cr 8.49Cr 58Cr 23Cr 295.98Cr 22Cr 22Cr 938.11Cr 7.88TCr 5.86Cr 5.23Cr 4.81Cr 4.37Cr 8.2Cr 554.91Cr 8.41Cr 57Cr 23Cr 292.88Cr 22Cr 22Cr 928.31Cr
Projected Income Statement - Annual - GC Cell Corporation
Logo GC Cell Corporation
GC Cell Corp is a Korea-based company principally engaged in the provision of specimen testing services. The Company is principally engaged in the provision of specimen testing services, which are all types of tests performed using specimens collected from patients for the purpose of diagnosing, preventing and treating diseases. The Company is engaged in the development, research, manufacture and distribution of cell therapy products. In addition, the Company is also engaged in the cord blood storage businesses and bio logistic businesses.
Employees
674
Date Price Change Volume
03/26/03 ₩9,890.00 -1.98% 47,744
02/26/02 ₩10,090.00 -0.10% 52,173
30/26/30 ₩10,100.00 +3.59% 72,755
29/26/29 ₩9,750.00 -6.88% 1,33,453
28/26/28 ₩10,470.00 -19.15% 3,40,615
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - GC Cell Corporation
  1. Stock Market
  2. Stocks
  3. A144510 Stock